Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8807293 | Diagnostic Histopathology | 2018 | 5 Pages |
Abstract
Epstein Barr virus-positive mucocutaneous ulceration (EBVMCU) is an uncommon entity first described in 2010. This lymphoproliferative disorder was first described in immunocompromised patients presenting with well-defined ulceration involving the oral cavity, skin and gastrointestinal tract. The first case series suggested that EBVMCU is generally self-limiting and likely to resolve without treatment. However, since then, additional cases reported have described a more heterogeneous course. Many people are infected with Epstein Barr virus (EBV) at a young age and this usually has a self-limiting course. However, immunosuppression due to any cause, including age-related immunosenescene may facilitate a wide spectrum of EBV-related lymphoid hyperplasia and lymphoma. We describe a case of oral presentation of EBVMU in a patient on long term immunosuppressants.
Related Topics
Health Sciences
Medicine and Dentistry
Pathology and Medical Technology
Authors
Jon Griffin, Olive Allsobrook, Syed Ali Khurram, Anne Hegarty, Nick J. Morley, Malee Fernando,